The search for a cure for AIDS: If it ain’t broke…
March 12, 2014 Editor 0
To your very good health, sir!
GENE therapy usually works by repairing a broken gene or creating a new one where none previously existed. Breaking a working gene to effect a cure is a novel approach. That, though, is what Carl June of the University of Pennsylvania and his colleagues are trying to do. As they explain in the New England Journal of Medicine, by damaging a gene called CCR5 they hope to treat—and possibly cure—infection with HIV, the virus that causes AIDS.CCR5 encodes a protein that sits on the surface membranes of T-lymphocytes, cells which are part of the immune system. The protein’s job is to latch onto signal molecules called chemokines. Unfortunately, it also latches onto strains of HIV, assisting their passage into the lymphocyte, where the virus then reproduces.A consequence is that those whose CCR5 genes are broken are immune to infection by these strains. Moreover, an HIV patient called Timothy Brown (pictured) who, in 2007 and 2008, had bone-marrow transplants from a donor with broken CCR5…
- AIDS: Bursting HIV’s bubble
- Systematic Review of the Performance of HIV Viral Load Technologies on Plasma Samples.
- mHealth for HIV Treatment & Prevention: A Systematic Review of the Literature.
- Researchers pioneer world’s first HIV/AIDS nanomedicines
- HIV and mothers’ milk: As luck would have it
- Tapping into the gaming community in tackling global challenges
Categories: The Economist
Subscribe to our stories
- Giving Francophone African incubators the keys to accelerate growth entrepreneurship February 13, 2018
- Is acceleration the panacea for scaling growth entrepreneurs? Reflections from XL Africa February 13, 2018
- Why providing pre-seed and seed capital is the essential step to bringing West Africa and Sahel’s entrepreneurs to the next level February 13, 2018
- Global Investment Competitiveness: New Insights on FDI February 2, 2018
- BioInnovate Africa phase II launched February 2, 2018